| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | CCT-137690 |
|---|
| Description | CCT137690 is a highly selective and orally bioavailable inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 15 nM, 25 nM and 19 nM, respectively. Displays anti-tumor activities both in vitro and in vivo. B. MW: 551.48. Purity ≥98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-[[4-[6-bromo-2-[4-(4-methylpiperazin-1-yl)phenyl]-1H-imidazo[4,5-b]pyridin-7-yl]piperazin-1-yl]methyl]-5-methyl-1,2-oxazole |
|---|
| Gene, Accession, CAS # | CAS: 1095382-05-0 |
|---|
| Catalog # | B1935-5 |
|---|
| Price | |
|---|
| Order / More Info | CCT-137690 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|